Etexilate

Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date

...y of the oral direct thrombin inhibitor dabigatran etexilate with the current standard therapy, warfarin (targe...patients with atrial fibrillation (AF). Dabigatran etexilate is an oral anticoagulant in Phase III development ...ll as several other therapeutic areas. Dabigatran etexilate is not approved by the FDA. RE-LY(R) is the large...

Pill Equals Injection in Preventing Clots After Hip Replacement

... the two protective treatments FRIDAY, Sept. 14 (HealthDay News) -- In a head-to-head trial, Swedish researchers found that a pill called dabigatran etexilate (DE) is just as effective as an injected drug, enoxaparin, in reducing the risk of blood clots after total hip replacement surgery. As reported in ...

Etexilate in Medical Technology

Boehringer Ingelheim Announces Enrollment is Complete for the Largest Atrial Fibrillation Outcomes Trial - The RE-LY(TM) Study

...gational oral direct thrombin inhibitor dabigatran etexilate for the prevention of stroke and systemic embolism...II clinical trial program investigating dabigatran etexilate in more than 34,000 patients for the prevention an...mg twice daily or 110mg twice daily) of dabigatran etexilate with open label warfarin sodium in patients with n...

The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor

... Study results outline dabigatran etexilate as potential thromboprophylaxis therapy for pa...the RE-NOVATE study, which investigated dabigatran etexilate as a potential therapy for patients undergoing tot...eported after hospital discharge in the dabigatran etexilate groups. Data from frequent liver function monitor...

Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis

... rate of major bleeding associated with dabigatran etexilate was similar to enoxaparin. The incidence of liver ...is (ISTH) today.(i) In clinical trials, dabigatran etexilate is given orally once daily and does not require ti...that both oral doses (220mg; 150 mg) of dabigatran etexilate were non-inferior to injected enoxaparin at reduci...